Vaxcyte
Latest round
- Series D
Last raised
- Mar 2020
Total raised
- $206M
Investors
- 11
About Vaxcyte
Vaxcyte, Inc.Founded in 2013 and headquartered in San Carlos, US, Vaxcyte, Inc. specializes in vaccine development. The company, co-founded by Grant Pickering and Jeff Fairman, has shifted focus to pneumococcal conjugate vaccines, reflecting its commitment to combatting significant bacterial threats.Vaxcyte focuses on creating advanced vaccines targeting bacterial infections, particularly invasive pneumococcal disease, Group A Streptococcus, periodontitis, and Shigella. Its key offerings include the VAX-31 and VAX-24 pneumococcal conjugate vaccines, which utilize innovative synthetic techniques to effectively neutralize complex bacterial defenses.Vaxcyte's revenue generation is based on the development and commercialization of its vaccine products via strategic partnerships with healthcare providers and distributors. Revenue is expected to come from the sales of VAX-31 and VAX-24 following regulatory approval, supported by ongoing R&D to enhance its vaccine portfolio. The company is focusing on expanding its operations into new geographical markets, particularly in North America and Europe, by 2024. Vaxcyte aims to strengthen its position in the global vaccine market through strategic initiatives and partnerships.
Who invested in Vaxcyte
11 investors across 4 rounds
See all investors in Vaxcyte
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Vaxcyte
Who invested in Vaxcyte?
Vaxcyte has 11 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vaxcyte raised?
Vaxcyte has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Vaxcyte last raise money?
Vaxcyte's most recent round on record is a Series D, in Mar 2020.
What does Vaxcyte do?
Vaxcyte is a biotechnology company.
Where is Vaxcyte headquartered?
Vaxcyte is headquartered in San Carlos, US.
Which VCs invest in companies like Vaxcyte?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Vaxcyte's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Vaxcyte? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.